FDA-approved alternatives in the melanocortin family do exist, such as bremelanotide (Vyleesi) for female sexual desire and afamelanotide (Scenesse) for severe light sensitivity
139 SunL.ZongG.PanA.YeX.LiH.YuZ.et al (2013)
Retatrutide is characterized in research literature for a tuned potency hierarchy: highest activity at GIP receptors for lipid buffering research, moderate activity at GLP-1 receptors for satiety pathway investigation, and carefully calibrated glucagon receptor activity for energy expenditure modeling without the hyperglycemia associated with unbalanced glucagon stimulation in research models
Meyerhof W, Batram C, Kuhn C, Brockhoff A, Chudoba E, Bufe B, et al
Delivers active peptides over 68 hours, ensuring consistent recovery support where its needed most
See our Compliance Policy